These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15061243)

  • 1. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample.
    Kavanagh DJ; Waghorn G; Jenner L; Chant DC; Carr V; Evans M; Hemnan H; Jablensky A; McGrath JJ
    Schizophr Res; 2004 Feb; 66(2-3):115-24. PubMed ID: 15061243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance misuse at presentation to an early psychosis program.
    Van Mastrigt S; Addington J; Addington D
    Soc Psychiatry Psychiatr Epidemiol; 2004 Jan; 39(1):69-72. PubMed ID: 15022049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of substance misuse in first-episode psychosis.
    Cantwell R; Brewin J; Glazebrook C; Dalkin T; Fox R; Medley I; Harrison G
    Br J Psychiatry; 1999 Feb; 174():150-3. PubMed ID: 10211169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses.
    Caton CL; Drake RE; Hasin DS; Dominguez B; Shrout PE; Samet S; Schanzer B
    Arch Gen Psychiatry; 2005 Feb; 62(2):137-45. PubMed ID: 15699290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressed emotion as predictor of relapse in patients with comorbid psychoses and substance use disorder.
    Pourmand D; Kavanagh DJ; Vaughan K
    Aust N Z J Psychiatry; 2005 Jun; 39(6):473-8. PubMed ID: 15943649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of substance misuse among individuals with severe mental illness in São Paulo.
    Rossi Menezes P; Ratto LR
    Soc Psychiatry Psychiatr Epidemiol; 2004 Mar; 39(3):212-7. PubMed ID: 14999454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DSM-V research agenda: substance abuse/psychosis comorbidity.
    Rounsaville BJ
    Schizophr Bull; 2007 Jul; 33(4):947-52. PubMed ID: 17556751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of socio-demographic and substance use correlates in early-onset psychosis.
    Paruk S; Jhazbhay K; Singh K; Sartorius B; Burns JK
    Early Interv Psychiatry; 2018 Jun; 12(3):339-347. PubMed ID: 27038079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s.
    Donoghue K; Medley I; Brewin J; Glazebrook C; Mason P; Cantwell R; Jones PB; Harrison G; Doody GA
    Soc Psychiatry Psychiatr Epidemiol; 2011 Feb; 46(2):137-42. PubMed ID: 20043146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity in psychosis at first hospitalization.
    Strakowski SM; Tohen M; Stoll AL; Faedda GL; Mayer PV; Kolbrener ML; Goodwin DC
    Am J Psychiatry; 1993 May; 150(5):752-7. PubMed ID: 8480821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance use in adolescence and psychosis: clarifying the relationship.
    Barkus E; Murray RM
    Annu Rev Clin Psychol; 2010; 6():365-89. PubMed ID: 20192802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.
    Moore E; Mancuso SG; Slade T; Galletly C; Castle DJ
    Aust N Z J Psychiatry; 2012 Sep; 46(9):864-78. PubMed ID: 22472772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescent Substance Misusers with and without Delinquency: Death, Mental and Physical Disorders, and Criminal Convictions from Age 21 to 45.
    Larm P; Silva TC; Hodgins S
    J Subst Abuse Treat; 2015 Dec; 59():1-9. PubMed ID: 26342514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of psychosis/substance abuse comorbidity. Clinical-epidemiological findings from different treatment settings in a large German city].
    Schnell T; Neisius K; Daumann J; Gouzoulis-Mayfrank E
    Nervenarzt; 2010 Mar; 81(3):323-8. PubMed ID: 20232511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
    Green AI; Tohen MF; Hamer RM; Strakowski SM; Lieberman JA; Glick I; Clark WS;
    Schizophr Res; 2004 Feb; 66(2-3):125-35. PubMed ID: 15061244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
    Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
    Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.